Clinical Trials Browser

Phase 1 × birinapant × Tumor-Agnostic × Clear all

NCT00993239 2016-03-03

Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma

Phase 1 Completed

Neoplasms